Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy AnaptysBio stock

Learn how to easily invest in AnaptysBio stock.

AnaptysBio Inc is a biotechnology business based in the US. AnaptysBio shares (ANAB) are listed on the NASDAQ and all prices are listed in US Dollars. AnaptysBio employs 102 staff and has a trailing 12-month revenue of around $24.1 million.

How to buy shares in AnaptysBio

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ANAB – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

AnaptysBio stock price (NASDAQ: ANAB)

Use our graph to track the performance of ANAB stocks over time.

AnaptysBio shares at a glance

Information last updated 2022-10-02.
Latest market close$26.97
52-week range$18.20 - $37.89
50-day moving average $24.23
200-day moving average $25.89
Wall St. target price$27.71
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-2.76

Buy AnaptysBio shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy AnaptysBio stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

AnaptysBio price performance over time

Historical closes compared with the close of $26.97 from 2022-10-04

1 week (2022-09-28) 3.18%
1 month (2022-09-02) 8.57%
3 months (2022-07-05) 23.04%
6 months (2022-04-01) N/A
1 year (2021-10-04) -1.24%
2 years (2020-10-05) 67.93%
3 years (2019-10-04) 33.23
5 years (2017-10-05) 35.95

AnaptysBio financials

Revenue TTM $24.1 million
Gross profit TTM $-35,321,000
Return on assets TTM -11.44%
Return on equity TTM -31.31%
Profit margin 0%
Book value $10.78
Market capitalisation $720.4 million

TTM: trailing 12 months

AnaptysBio share dividends

We're not expecting AnaptysBio to pay a dividend over the next 12 months.

AnaptysBio share price volatility

Over the last 12 months, AnaptysBio's shares have ranged in value from as little as $18.2 up to $37.89. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while AnaptysBio's is 0.1211. This would suggest that AnaptysBio's shares are less volatile than average (for this exchange).

AnaptysBio overview

AnaptysBio, Inc. , a clinical stage biotechnology company, engages in developing therapeutic product candidates for inflammation and immuno-oncology indications. Its products include Imsidolimab, an antibody that inhibits the interleukin-36 receptor (IL-36R) for the treatment of various dermatological inflammatory diseases; Rosnilimab, an anti-PD-1 agonist antibody program designed to augment PD-1 signaling through rosnilimab treatment to suppress T-cell driven human inflammatory diseases; and ANB032, an anti-BTLA modulator antibody applicable to human inflammatory diseases associated with lymphoid and myeloid immune cell dysregulation. The company also focuses on developing various antibody programs that are advanced to preclinical and clinical milestones under its collaborations. It has a collaboration and license agreement with GlaxoSmithKline, Inc. and Bristol-Myers Squibb; and license agreements with United Kingdom Research and Innovation, as well as Millipore Corporation. The company was formerly known as Anaptys Biosciences, Inc.

Frequently asked questions

What percentage of AnaptysBio is owned by insiders or institutions?
Currently 0.346% of AnaptysBio shares are held by insiders and 121.371% by institutions.
How many people work for AnaptysBio?
Latest data suggests 102 work at AnaptysBio.
When does the fiscal year end for AnaptysBio?
AnaptysBio's fiscal year ends in December.
Where is AnaptysBio based?
AnaptysBio's address is: 10770 Wateridge Circle, San Diego, CA, United States, 92121-5801
What is AnaptysBio's ISIN number?
AnaptysBio's international securities identification number is: US0327241065
What is AnaptysBio's CUSIP number?
AnaptysBio's Committee on Uniform Securities Identification Procedures number is: 032724106

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site